Target intelligence / Profile preview

Nei-like DNA glycosylase 2 (NEIL2)

Target
NEIL2
Molecular classification
Enzyme, DNA glycosylase/AP lyase, Member of the Fpg/Nei family of DNA glycosylases
01

Overview

Nei-like DNA glycosylase 2 (NEIL2) is a DNA repair enzyme in the Fpg/Nei glycosylase family that recognizes and excises oxidized DNA bases, particularly cytosine-derived lesions such as 5-hydroxyuracil and 5-hydroxycytosine, and acts as a DNA glycosylase/AP lyase. NEIL2 initiates the base excision repair (BER) pathway by removing damaged bases and introducing DNA strand breaks at abasic sites. Unlike some other glycosylases, NEIL2 preferentially acts on single-stranded DNA and DNA bubble structures, making it especially important for the repair of transcribed genes and regions involved in active transcription, supporting its role in transcription-coupled BER (TC-BER). NEIL2 interacts with RNA polymerase II and other DNA repair and transcription factors, is involved in the maintenance of genome stability, and also contributes to processes such as epigenetic demethylation and regulation of innate immunity. Dysfunction or deficiency in NEIL2 has been linked to cancer susceptibility, neurodevelopmental disorders, and specific congenital diseases. There are currently no drugs known to selectively target NEIL2 in clinical use.

Other names
Endonuclease VIII-like 2NEH2NEI2FLJ31644MGC2832MGC4505DNA glycosylase/AP lyase Neil2DNA-(apurinic or apyrimidinic site) lyase Neil2Nei homolog 2Nei-like protein 2endonuclease 8-like 2
02

Mechanism of action

Not established for drugs (no known clinical drugs selectively target NEIL2 as of current evidence); General mechanism: excision of oxidized bases, introduction of strand breaks at abasic sites by β,δ-elimination during BER

03

Biological functions

Base excision repair (BER) of oxidatively damaged DNAMaintenance of genome stabilityRegulation of transcription-coupled repair (TC-BER)Participation in epigenetic demethylationRegulation of innate immunity (repair-dependent and independent mechanisms)
04

Disease associations

Cancer (mutation and deficiency associated with increased genomic instability and cancer risk)Neurodevelopmental defects (e.g., cranial neural crest cell differentiation)Leber congenital amaurosis 17Cockayne syndrome
05

Safety considerations

Potential genomic instability and increased cancer risk if NEIL2 is inhibited or dysfunctionalPossible off-target effects in neural development and immune regulation

Beyond the preview

Go deeper on Nei-like DNA glycosylase 2 (NEIL2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nei-like DNA glycosylase 2 (NEIL2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call